Dexrazoxane
Who holds supplier records for Dexrazoxane? 8 organisations hold a current record for Dexrazoxane: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3), China (3) and Netherlands (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Dexrazoxane: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dexrazoxane
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dexrazoxane. Country is the organisation's recorded country, not necessarily the manufacturing site.
- GLAND PHARMA LTDIndia Company GMP cert on recordActive DMF 27826, 23172 · latest filing Feb 2014
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 37716 · latest filing Nov 2022
- BIOCARE PHARMACEUTICAL LTDChinaActive DMF 21542 · latest filing Apr 2008
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 34694 · latest filing Mar 2020
- Porton Pharma Solutions Ltd.ChinaActive DMF 38186 · latest filing Mar 2023
- STERLING WISCONSIN LLCActive DMF 18336 · latest filing May 2005
- TAPI NL BVNetherlandsActive DMF 19002 · latest filing Dec 2005
- YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTDChinaActive DMF 42432 · latest filing Aug 2025
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Dexrazoxane are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- BOEHRINGER INGELHEIM CHEMICALS INCInactive DMF 15184 · filed Dec 2000
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Dexrazoxane is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1738).
Chemical identity
- IUPAC name
- 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione
- Canonical SMILES
- C[C@@H](CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2
- InChIKey
- BMKDZUISNHGIBY-ZETCQYMHSA-N
- Synonyms
- ADR-529, Cardioxane, Dexrazoxane, Dexrazoxano, ICRF-187, NSC-169780, Razoxane, d-, Razoxane (+)-form, Razoxane, (s)-, Dextrorazoxane, Dexrazoxanum, ADR 529
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dexrazoxane?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Dexrazoxane: GLAND PHARMA LTD (India), APITORIA PHARMA PRIVATE LTD (India), BIOCARE PHARMACEUTICAL LTD (China), MSN Laboratories Private Limited (India), Porton Pharma Solutions Ltd. (China), STERLING WISCONSIN LLC, TAPI NL BV (Netherlands) and YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTD (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Dexrazoxane Drug Master Files are active?
GLAND PHARMA LTD (DMF 27826, 23172), APITORIA PHARMA PRIVATE LTD (DMF 37716), BIOCARE PHARMACEUTICAL LTD (DMF 21542), MSN Laboratories Private Limited (DMF 34694), Porton Pharma Solutions Ltd. (DMF 38186), STERLING WISCONSIN LLC (DMF 18336), TAPI NL BV (DMF 19002) and YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTD (DMF 42432). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Dexrazoxane records mean?
1 organisation has only inactive Type II DMFs for Dexrazoxane. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Dexrazoxane supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dexrazoxane?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.